In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Pediatrix trades slightly above its fair value by 2.7%, with valuations ranging widely from $9.59 to $399.29, reflecting high volatility (CV 165.6%) and significant downside risk (63.9%). Strong profitability and liquidity contrast with low growth, indicating stable operations but limited expansion. The wide Monte Carlo distribution signals elevated uncertainty affecting valuation confidence.